Target the Tumor. Spare the Body | Newswise
[ad_1] Newswise — Exhaustion creeps in. Appetite vanishes. Hair thins. The person in the mirror looks gaunt. It’s the paradox of cancer treatment: The same drugs meant to save a life can also wear the body down. Nick Housley, assistant professor in Georgia Tech’s School of Biological Sciences, wants to change that. He studies where […]
Hims & Hers shares surge after Novo Nordisk drops patent infringement case over compounded weight loss drugs
[ad_1] Novo Nordisk has dropped its legal case against telehealth provider Hims & Hers over patent infringement, after the two companies agreed Hims would sell Novo’s branded medicines through its platform. “We have decided to drop the current court proceedings and, of course, we reserve to bring that back if need be, but I don’t […]
Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’
[ad_1] Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight management in adults and adolescents. (Photo by Steve Christo – Corbis/Corbis via Getty Images) Steve Christo – Corbis | Corbis News | Getty Images The chief executive of drugmaker Zealand Pharma sought to calm investors about the […]
Why Novo Nordisk’s Ireland expansion is key to fighting off Eli Lilly
[ad_1] Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its production capacities to make the newly launched Wegovy pill, the Danish drugmaker said Monday. The news comes about two months after Novo launched its blockbuster weight loss drug Wegovy in pill form in the U.S. market, […]
These 4 charts show the scale of Novo Nordisk’s woes
[ad_1] Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe’s most valuable company. But its troubles are stacking up and today the stock trades at just a quarter of what it did at its peak less than two years ago. Pricing pressure, fierce competition, and pipeline setbacks […]
Novo Nordisk trial ‘own goal’ sparks flurry of analyst downgrades
[ad_1] Analysts added to the sour mood around Novo Nordisk , racing to cut price targets on the stock, after the Danish drugmaker published disappointing trial results on what it hoped to be its next big weight loss drug. The drug, CagriSema didn’t meet the key goal of matching rival medicine Zepbound, developed by Eli […]
Novo Nordisk sinks 10% after weight loss drug fails to match Eli Lilly’s in trial
[ad_1] Novo Nordisk stock fell over 10% Monday after it said its next-generation weight loss drug didn’t meet its primary target. The drug, CagriSema, didn’t achieve its primary endpoint of demonstrating non-inferiority on weight loss when compared to Eli Lilly‘s rival drug tirzepatide after 84 weeks, Novo said in a statement Monday morning. Eli Lilly‘s […]
Novo Nordisk CEO sees 15 million patient opportunity in Medicare coverage for obesity drugs
[ad_1] Novo Nordisk CEO Mike Doustdar on Wednesday said the company is aiming to capture around 15 million new patients, at least initially, when Medicare starts covering obesity treatments for the first time later this year. Around 67 million Americans are covered by Medicare, but “when you take a look at specifically our products and […]
Changing the Playing Field in Nickel Catalysis | Newswise
[ad_1] BYLINE: Tracy Crane, Department of Chemistry Newswise — Researchers at the University of Illinois Urbana-Champaign have reported a breakthrough in nickel catalysis that harnesses a rare oxidation state of nickel that has proved challenging to control yet is highly valued for its potential to facilitate important chemical reactions. The researchers, led by Liviu Mirica, a […]
High blood pressure drug recalled over low blood pressure pill mix-up – National | Globalnews.ca
[ad_1] Health Canada is warning Canadians to check their medication after two lots of MAR-Amlodipine 5 mg tablets were recalled, as some bottles may contain the wrong drug. Marcan Pharmaceuticals Inc. says certain bottles labelled as MAR-Amlodipine may contain midodrine 2.5 mg tablets, a medication used to treat low blood pressure. Meanwhile, MAR-Amlodipine, the actual […]